Technology News and Research

RSS

iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine

iBio, Inc. today announced that its proprietary iBioLaunch Platform successfully expressed the hookworm-derived molecule known as NaAPR1M-74, which will be evaluated as a potential vaccine candidate for human hookworm disease.

26 May 2011

Patterson Companies fourth quarter consolidated sales increase 9% to $883,819,000

Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.

26 May 2011

ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that favorable clinical data on two ImmunoGen-created TAP compounds - IMGN901 and SAR3419 - are being presented at the ASCO 2011 Annual Meeting taking place in Chicago, IL, June 4-8, 2011.

26 May 2011

HP, Healthways sign 10-year applications and technology services outsourcing agreement

HP Enterprise Services and Healthways, Inc. today announced the signing of a 10-year, $380 million applications and technology services outsourcing agreement to support growth and expand value to Healthways' customers.

26 May 2011

Health Media Syndicate releases LiVe 2.0 for teens to stay healthy

Health Media Syndicate announced the release of LiVe 2.0, the newest addition to the nation's largest teen fitness public service campaign that is being deployed by healthcare organizations.

26 May 2011

Quantum sensors could aid in development of new drugs and nanomedicine

Groundbreaking research has shown a quantum atom has been tracked inside a living human cell and may lead to improvements in the testing and development of new drugs.

26 May 2011

Impact of gaming devices on finger and wrist pain in children presented at EULAR 2011

For the first time, results on the impact of gaming devices on finger and wrist pain in children were presented today at the EULAR 2011 Annual Congress. Data comparing two schools in the USA demonstrate that young children experience high levels of pain following long term use of gaming devices and mobile phones indicating that excessive gaming may negatively impact on joint health.

26 May 2011

Consistency and efficiency of FDA's medical device review process raises concern

Two-thirds of small medical device and diagnostic companies--the drivers of innovation in the sector--are obtaining clearance for new products in Europe first, suggesting delayed market entry in the U.S., according to a comprehensive industrywide survey about FDA's 510(k) product review process by researchers at Northwestern University.

26 May 2011

USC engineers to develop robot vision-based mobility aid for visually impaired people

For the visually impaired, navigating city streets or neighborhoods has constant challenges. And most such people still must rely on a very rudimentary technology-a simple cane-to help them make their way through a complex world.

26 May 2011

Neoprobe, Devicor sign gamma detection device asset purchase agreement

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.

26 May 2011

NIST releases suite of green tea reference materials for manufacturers

The National Institute of Standards and Technology has released a suite of green tea reference materials to help manufacturers evaluate the composition of their products and assure researchers of the accuracy of analytical methods for studying the human health effects of this popular beverage and dietary supplement.

26 May 2011

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

GE Healthcare today announced 510k clearance of CoreScan - a widely-accessible application dedicated to quickly and accurately quantifying visceral adipose tissue, or visceral "belly" fat, during body composition analysis.

26 May 2011

Lx Therapies, BioCis partner to form Laurantis Pharma

BioCis Pharma Oy and Oy Lx Therapies Ltd. announced today that the companies have combined to create Laurantis Pharma Oy, a clinical-stage specialty pharmaceutical development company.

26 May 2011

MAXIMUS offers eHealth Literacy Services for state and community programs

MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it is now offering eHealth Literacy Services to help state and community programs meet the communication and engagement challenges facing consumers and providers using the new health information technology infrastructure.

25 May 2011

FDA grants approval for CSI to complete enrollment in ORBIT II IDE coronary clinical trial

Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.

25 May 2011

LifeLinks introduces real time video interpreting services for 180 spoken languages

Building on their success in video relay interpreting, LifeLinks has introduced real time captioning and recording between more than 180 languages including American Sign Language.

25 May 2011

CRT, Cancer Research UK and Centella partner to launch clinical development of CEN-209

Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - have partnered with Centella Therapeutics, Inc. of Palo Alto, California, to develop, manufacture and trial a promising new drug, CEN-209 in cancer patients with solid tumours.

25 May 2011

Elan, Proteostasis create innovative drug discovery initiative for neurodegenerative disorders

Proteostasis Therapeutics and Elan Corporation today announced a strategic business relationship to advance Proteostasis' platform for the discovery and development of disease-modifying, small molecule drugs and diagnostics for the treatment of neurodegenerative disorders such as Parkinson's, Huntington's, multiple sclerosis and amyotrophic lateral sclerosis, and a broad array of dementia-related diseases including Alzheimer's.

25 May 2011

Evotec, PsychoGenics partner to offer integrated CNS drug discovery solutions

PsychoGenics Inc. today announced that it has entered into a strategic alliance with Evotec AG to provide integrated CNS drug discovery solutions to pharmaceutical and biotech companies.

25 May 2011

Imec, Wipro create joint initiative to develop nanoelectronics and NEMS-based solutions

Imec today announced the establishment of imec India in Bangalore, Karnataka, making a first step towards the Indian market with the signing of an R&D partnership agreement with Wipro Technologies, the Global Information Technology, Consulting and Outsourcing business of Wipro Limited.

25 May 2011

Technology News and Research

iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine

Patterson Companies fourth quarter consolidated sales increase 9% to $883,819,000

ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011

HP, Healthways sign 10-year applications and technology services outsourcing agreement

Health Media Syndicate releases LiVe 2.0 for teens to stay healthy

Quantum sensors could aid in development of new drugs and nanomedicine

Impact of gaming devices on finger and wrist pain in children presented at EULAR 2011

Consistency and efficiency of FDA's medical device review process raises concern

USC engineers to develop robot vision-based mobility aid for visually impaired people

Neoprobe, Devicor sign gamma detection device asset purchase agreement

NIST releases suite of green tea reference materials for manufacturers

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

Lx Therapies, BioCis partner to form Laurantis Pharma

MAXIMUS offers eHealth Literacy Services for state and community programs

FDA grants approval for CSI to complete enrollment in ORBIT II IDE coronary clinical trial

LifeLinks introduces real time video interpreting services for 180 spoken languages

CRT, Cancer Research UK and Centella partner to launch clinical development of CEN-209

Elan, Proteostasis create innovative drug discovery initiative for neurodegenerative disorders

Evotec, PsychoGenics partner to offer integrated CNS drug discovery solutions

Imec, Wipro create joint initiative to develop nanoelectronics and NEMS-based solutions

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News